Esparma GmbH,   Germany

Treatment for nephrolithiasis
Granules for solution for oral administration.
Treatment for nephrolithiasis
The tablets are effervescent.
Antifungal agent
Vaginal cream 2%.
antibiotic

Powder for solution for oral administration 3 g.


Expectorant of plant origin
Syrup
An expectorant of plant origin.
Emulsion for inhalation and external application.
antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 10 mg and 20 mg.

metabolic
Film coated tablets 600 mg.
For 10 tablets in a blister of PVC / A1 foil. By 3, 6 or 10 blisters together with instructions for use in cardboard pack.

metabolic
Concentrate for the preparation of a solution for infusions of 25 mg / ml.

expectorant mucolytic

Powder for solution for oral administration, 200 mg and 600 mg.

The anticongestive agent is alpha-adrenomimetic.

Nasal drops 0.05% and 0.1%.

For 10 ml in a bottle of amber glass (hydrolytic, class SH EP), sealed with a stopper pipette and a polypropylene screw cap. Each vial with instructions for use is placed in a cardboard box.
The anticongestive agent is alpha-adrenomimetic.

Nasal Spray 0,1%.

10 ml in a bottle of amber glass (hydrolytic, class III EP) with a spraying device and a nasal adapter with a protective cap. Each vial with instructions for use is placed in a cardboard box.
antibiotic-macrolide.
The tablets covered with a cover of 150 mg.